Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms

NCT07638553 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT07638553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07638553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Phase 3
Overall status
Recruiting
Start date
June 30, 2026
Completion date
June 30, 2030
Enrollment
172 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, depressive sympotoms, psilocybin